Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 176 citing articles:

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 773
Suicide and suicide risk
Gustavo Turecki, David A. Brent, David Gunnell, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 768
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286
Molecular logic of mTORC1 signalling as a metabolic rheostat
Alexander J. Valvezan, Brendan D. Manning
Nature Metabolism (2019) Vol. 1, Iss. 3, pp. 321-333
Closed Access | Times Cited: 258
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
Biochemical Pharmacology (2020) Vol. 177, pp. 113935-113935
Open Access | Times Cited: 188
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
David E. Olson
Journal of Experimental Neuroscience (2018) Vol. 12
Open Access | Times Cited: 185
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 185
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
Chun Yang, Jianjun Yang, Ailin Luo, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Satoshi Deyama, Ronald S. Duman
Pharmacology Biochemistry and Behavior (2019) Vol. 188, pp. 172837-172837
Open Access | Times Cited: 148
Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
Lijia Chang, Kai Zhang, Yaoyu Pu, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 181, pp. 53-59
Closed Access | Times Cited: 146
A historical review of antidepressant effects of ketamine and its enantiomers
Wei Yan, Lijia Chang, Kenji Hashimoto
Pharmacology Biochemistry and Behavior (2020) Vol. 190, pp. 172870-172870
Open Access | Times Cited: 140
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
Domenico De Berardis, Michele Fornaro, Alessandro Valchera, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2888-2888
Open Access | Times Cited: 159
Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Ronald S. Duman, Ryota Shinohara, Manoela V. Fogaça, et al.
Molecular Psychiatry (2019) Vol. 24, Iss. 12, pp. 1816-1832
Open Access | Times Cited: 129
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
An update on ketamine and its two enantiomers as rapid-acting antidepressants
Kai Zhang, Kenji Hashimoto
Expert Review of Neurotherapeutics (2018) Vol. 19, Iss. 1, pp. 83-92
Closed Access | Times Cited: 123
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Yunfeng Li
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107494-107494
Closed Access | Times Cited: 123
Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties
Bruk Getachew, Joseph I Aubee, Richard S. Schottenfeld, et al.
BMC Microbiology (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 111
Ketamine applications beyond anesthesia – A literature review
Agata Nowacka, Małgorzata Borczyk
European Journal of Pharmacology (2019) Vol. 860, pp. 172547-172547
Closed Access | Times Cited: 102
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
Kai Zhang, Chun Yang, Lijia Chang, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 100
The role of vitamin C in stress-related disorders
Bettina Moritz, Ariana Ern Schmitz, Ana Lúcia S. Rodrigues, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 85, pp. 108459-108459
Closed Access | Times Cited: 98
Contribution of sleep deprivation to suicidal behaviour: A systematic review
Alejandro Porras‐Segovia, M. Mercedes Pérez-Rodríguez, Pilar López-Esteban, et al.
Sleep Medicine Reviews (2018) Vol. 44, pp. 37-47
Closed Access | Times Cited: 88
Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth
Calvin Ly, Alexandra C. Greb, Maxemiliano V. Vargas, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 452-460
Open Access | Times Cited: 87
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants
Bashkim Kadriu, Maximillian Greenwald, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 8-21
Open Access | Times Cited: 81
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Susan Ling, Felicia Ceban, Leanna M.W. Lui, et al.
CNS Drugs (2021) Vol. 36, Iss. 1, pp. 17-30
Closed Access | Times Cited: 80
Page 1 - Next Page

Scroll to top